Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
M3
(3)
Antibody
Unknown
Unknown
Metabolites
Unknown
M3
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GOVORESTAT
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
GOVORESTAT
×
Maximum Phase:
3
First Approval:
None
UNII:
6JLQ8K35KK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F3N3O3S2
Molecular Weight:
425.41
AlogP:
3.76
PSA:
85.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AMRUBICIN
(3)
Small molecule
DNA topoisomerase II alpha inhibitor
Unknown
Investigational
Unknown
AMRUBICIN
×
Maximum Phase:
3
First Approval:
None
UNII:
93N13LB4Z2
Molecule Type:
Small molecule
Molecular Formula:
C25H25NO9
Molecular Weight:
483.47
AlogP:
0.63
PSA:
176.61
HBD:
5.0
HBA:
#RotB:
3.0
Source:
VICRIVIROC MALEATE
(3)
Small molecule
C-C chemokine receptor type 5 antagonist
Unknown
Investigational
Unknown
VICRIVIROC MALEATE
×
Maximum Phase:
3
First Approval:
None
UNII:
EP3QG127N9
Molecule Type:
Small molecule
Molecular Formula:
C32H42F3N5O6
Molecular Weight:
649.71
AlogP:
4.5
PSA:
61.8
HBD:
0.0
HBA:
#RotB:
6.0
Source:
UBIDECARENONE
(3)
Small molecule
Supplement
Unknown
Investigational
Unknown
UBIDECARENONE
×
Maximum Phase:
3
First Approval:
None
UNII:
EJ27X76M46
Molecule Type:
Small molecule
Molecular Formula:
C59H90O4
Molecular Weight:
863.36
AlogP:
17.85
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
31.0
Source:
RILMENIDINE
(3)
Small molecule
Nischarin agonist
Unknown
Approved
Unknown
RILMENIDINE
×
Maximum Phase:
3
First Approval:
None
UNII:
P67IM25ID8
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O
Molecular Weight:
180.25
AlogP:
1.15
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TALAPORFIN SODIUM
(3)
Small molecule
Photosensitizing agent
Unknown
Investigational
Unknown
TALAPORFIN SODIUM
×
Maximum Phase:
3
First Approval:
None
UNII:
L63605PZ70
Molecule Type:
Small molecule
Molecular Formula:
C38H37N5Na4O9
Molecular Weight:
799.7
AlogP:
5.95
PSA:
235.66
HBD:
7.0
HBA:
#RotB:
12.0
Source:
FALDAPREVIR
(3)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Investigational
Unknown
FALDAPREVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
958X4J301A
Molecule Type:
Small molecule
Molecular Formula:
C40H49BrN6O9S
Molecular Weight:
869.84
AlogP:
6.3
PSA:
198.38
HBD:
4.0
HBA:
#RotB:
13.0
Source:
VADIMEZAN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
VADIMEZAN
×
Maximum Phase:
3
First Approval:
None
UNII:
0829J8133H
Molecule Type:
Small molecule
Molecular Formula:
C17H14O4
Molecular Weight:
282.3
AlogP:
3.19
PSA:
67.51
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TAVAPADON
(3)
Small molecule
Dopamine D1 receptor partial agonist
Unknown
Investigational
Unknown
TAVAPADON
×
Maximum Phase:
3
First Approval:
None
UNII:
PT4P8MJP8L
Molecule Type:
Small molecule
Molecular Formula:
C19H16F3N3O3
Molecular Weight:
391.35
AlogP:
3.56
PSA:
76.98
HBD:
1.0
HBA:
#RotB:
3.0
Source:
FOLITIXORIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
FOLITIXORIN
×
Maximum Phase:
3
First Approval:
None
UNII:
0SXY5ET48B
Molecule Type:
Small molecule
Molecular Formula:
C20H23N7O6
Molecular Weight:
457.45
AlogP:
-0.52
PSA:
193.98
HBD:
6.0
HBA:
#RotB:
7.0
Source:
RAC-3-N-BUTYLPHTHALIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
RAC-3-N-BUTYLPHTHALIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
822Q956KGM
Molecule Type:
Small molecule
Molecular Formula:
C12H14O2
Molecular Weight:
190.24
AlogP:
3.09
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
3.0
Source:
DELEOBUVIR
(3)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
DELEOBUVIR
×
Maximum Phase:
3
First Approval:
None
UNII:
58BU988K90
Molecule Type:
Small molecule
Molecular Formula:
C34H33BrN6O3
Molecular Weight:
653.58
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ARTEMISIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ARTEMISIN
×
Maximum Phase:
3
First Approval:
None
UNII:
Y1R67R7XWU
Molecule Type:
Small molecule
Molecular Formula:
C15H22O5
Molecular Weight:
282.34
AlogP:
2.39
PSA:
53.99
HBD:
0.0
HBA:
#RotB:
0.0
Source:
RIVOGLITAZONE
(3)
Small molecule
Peroxisome proliferator-activated receptor gamma agonist
Unknown
Investigational
Unknown
RIVOGLITAZONE
×
Maximum Phase:
3
First Approval:
None
UNII:
3A3N0634Q6
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O4S
Molecular Weight:
397.46
AlogP:
3.06
PSA:
82.45
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MK-0557
(3)
Small molecule
Neuropeptide Y receptor type 5 antagonist
Unknown
Investigational
Unknown
MK-0557
×
Maximum Phase:
3
First Approval:
None
UNII:
HVE36P8422
Molecule Type:
Small molecule
Molecular Formula:
C22H19FN4O3
Molecular Weight:
406.42
AlogP:
3.6
PSA:
86.11
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IMIGLITAZAR
(3)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
IMIGLITAZAR
×
Maximum Phase:
3
First Approval:
None
UNII:
7244710F59
Molecule Type:
Small molecule
Molecular Formula:
C28H26N2O5
Molecular Weight:
470.53
AlogP:
6.01
PSA:
94.15
HBD:
1.0
HBA:
#RotB:
11.0
Source:
TAGATOSE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TAGATOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
T7A20Y888Y
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.38
PSA:
118.22
HBD:
5.0
HBA:
#RotB:
5.0
Source:
ALTROPANE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALTROPANE
×
Maximum Phase:
3
First Approval:
None
UNII:
1Q4092099O
Molecule Type:
Small molecule
Molecular Formula:
C18H21FINO2
Molecular Weight:
429.27
AlogP:
3.88
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PREGNENOLONE SUCCINATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PREGNENOLONE SUCCINATE
×
Maximum Phase:
3
First Approval:
None
UNII:
6LN4W6JJK6
Molecule Type:
Small molecule
Molecular Formula:
C25H36O5
Molecular Weight:
416.56
AlogP:
4.93
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GALACTOSE
(3)
Small molecule
Unknown
Unknown
Approved
Unknown
GALACTOSE
×
Maximum Phase:
3
First Approval:
None
UNII:
7IOF6H4H77
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
VALILTRAMIPROSATE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALILTRAMIPROSATE
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPRAGLIFLOZIN L-PROLINE
(3)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
Unknown
Investigational
Unknown
IPRAGLIFLOZIN L-PROLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
M6N3GK48A4
Molecule Type:
Small molecule
Molecular Formula:
C26H30FNO7S
Molecular Weight:
519.59
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RIGOSERTIB
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIGOSERTIB
×
Maximum Phase:
3
First Approval:
None
UNII:
67DOW7F9GL
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO8S
Molecular Weight:
451.5
AlogP:
2.8
PSA:
120.39
HBD:
2.0
HBA:
#RotB:
11.0
Source:
APLAVIROC HYDROCHLORIDE
(3)
Small molecule
C-C chemokine receptor type 5 antagonist
Unknown
Investigational
Unknown
APLAVIROC HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
04D148Z3VR
Molecule Type:
Small molecule
Molecular Formula:
C33H44ClN3O6
Molecular Weight:
614.18
AlogP:
4.58
PSA:
119.41
HBD:
3.0
HBA:
#RotB:
10.0
Source:
ELOBIXIBAT
(3)
Small molecule
Ileal bile acid transporter inhibitor
Unknown
Investigational
Unknown
ELOBIXIBAT
×
Maximum Phase:
3
First Approval:
None
UNII:
865UEK4EJC
Molecule Type:
Small molecule
Molecular Formula:
C36H45N3O7S2
Molecular Weight:
695.9
AlogP:
6.14
PSA:
142.11
HBD:
3.0
HBA:
#RotB:
16.0
Source:
PELUBIPROFEN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
PELUBIPROFEN
×
Maximum Phase:
3
First Approval:
None
UNII:
1619C79FVJ
Molecule Type:
Small molecule
Molecular Formula:
C16H18O3
Molecular Weight:
258.32
AlogP:
3.4
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TARIBAVIRIN HYDROCHLORIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
TARIBAVIRIN HYDROCHLORIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
D22JZE246P
Molecule Type:
Small molecule
Molecular Formula:
C8H14ClN5O4
Molecular Weight:
279.68
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
MOSAPRIDE
(3)
Small molecule
Serotonin 3 (5-HT3) receptor antagonist
Unknown
Approved
Unknown
MOSAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
I8MFJ1C0BY
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClFN3O3
Molecular Weight:
421.9
AlogP:
3.09
PSA:
76.82
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TIAPRIDE
(3)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Investigational
Unknown
TIAPRIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
LAH70H9JPH
Molecule Type:
Small molecule
Molecular Formula:
C15H24N2O4S
Molecular Weight:
328.43
AlogP:
1.17
PSA:
75.71
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ROVATIRELIN
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
ROVATIRELIN
×
Maximum Phase:
3
First Approval:
None
UNII:
9DL0X410PY
Molecule Type:
Small molecule
Molecular Formula:
C16H22N4O4S
Molecular Weight:
366.44
AlogP:
0.68
PSA:
100.63
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DIANICLINE
(3)
Small molecule
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
Unknown
Investigational
Unknown
DIANICLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
Y0SNM34C6O
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
DALCETRAPIB
(3)
Small molecule
Cholesteryl ester transfer protein inhibitor
Unknown
Investigational
Unknown
DALCETRAPIB
×
Maximum Phase:
3
First Approval:
None
UNII:
3D050LIQ3H
Molecule Type:
Small molecule
Molecular Formula:
C23H35NO2S
Molecular Weight:
389.61
AlogP:
6.68
PSA:
46.17
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TESEVATINIB
(3)
Small molecule
Ephrin type-B receptor 4 inhibitor
Unknown
Investigational
Unknown
TESEVATINIB
×
Maximum Phase:
3
First Approval:
None
UNII:
F6XM2TN5A1
Molecule Type:
Small molecule
Molecular Formula:
C24H25Cl2FN4O2
Molecular Weight:
491.39
AlogP:
5.79
PSA:
59.51
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GOZETOTIDE
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
GOZETOTIDE
×
Maximum Phase:
3
First Approval:
None
UNII:
9AG41L3AOQ
Molecule Type:
Small molecule
Molecular Formula:
C44H62N6O17
Molecular Weight:
947.0
AlogP:
1.55
PSA:
370.07
HBD:
12.0
HBA:
#RotB:
35.0
Source:
OMEGA-3-PENTAENOIC ACIDS
(3)
Small molecule
Unknown
Unknown
Investigational
Unknown
OMEGA-3-PENTAENOIC ACIDS
×
Maximum Phase:
3
First Approval:
None
UNII:
317SQ4W8IJ
Molecule Type:
Small molecule
Molecular Formula:
C63H96O6
Molecular Weight:
949.45
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
178
179
180
181
182
183
184
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA